Tag Archives: modern

As Covid-19 vaccines begin to receive emergency approvals, the race begins to distribute the one product billions of people around the world will want. That is creating investment opportunities as traders examine the companies involved in the global launch. With multiple types of vaccines, supply chains involve hundreds of companies, …

NEW DELHI: The drug regulator has allowed human trials of the first local Covid mRNA vaccine candidate and preliminary results are likely to be available in March. It assumes importance as Covid-19 vaccines based on this platform, such as those from Pfizer-BioNtech and Moderna, are expected to have better efficacy, …

Vaccines can sometimes cause allergic reactions, but they are usually rare and short-lived. British regulators are investigating reports of allergic reactions in two people who received the new Pfizer COVID-19 vaccine on Tuesday, the first day of a vaccination program. Meanwhile, they are telling people to skip the vaccine if …

However, distributing the vaccines in India’s first mass vaccination campaign for adults could be a daunting task. It will require expanding India’s existing cold chain capacity at breakneck speed, especially in some of the most densely populated parts of the country, where such infrastructure is very limited. It will also …

The Modern Covid-19 vaccine, which the company recently found to be 94 percent effective, causes the human immune system to produce potent antibodies that last for at least three months, a study showed Thursday. Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), which co-developed the drug, studied …

“Do we really need a vaccine?” Former Indian cricketer Harbhajan Singh asked on Twitter Thursday, after which the internet politely reminded the spinner exactly why the Indians (and the world) needed him. No concrete medication in sight to COVID-19, a ray of hope appeared when some companies such as Pfizer …

Moderna Inc plans to apply for authorization for its coronavirus vaccine in the United States and Europe on Monday, after a new analysis showed the vaccine was highly effective in preventing Covid-19, without serious safety concerns. The primary analysis, which included 196 cases, found the vaccine to be 94.1 percent …

Moderna Inc said it will request emergency authorization from the United States and Europe for its Covid-19 vaccine on Monday based on the full results of a late-stage study showing its vaccine was 94.1% effective without serious safety concerns. . They also reported a 100% success rate in preventing severe …

Moderna Inc. said it would ask US and European regulators on Monday to allow emergency use of its COVID-19 the vaccine, as the results of a new study confirm that vaccines offer strong protection accelerating the race to start limited vaccines as they coronavirus the ruckus gets worse. Several candidate …

US-based pharmaceutical company Moderna Inc said it will apply for emergency authorization from the US and Europe of its COVID-19 vaccine on Monday based on the full results of a late-stage study showing that their vaccine was 94.1% effective without serious safety concerns. The pharmaceutical company also reported a 100% …